Company Filing History:
Years Active: 2007-2014
Title: Kathryn Bronstein: Innovator in Medical Treatments
Introduction
Kathryn Bronstein is a prominent inventor based in Jupiter, FL (US). She has made significant contributions to the field of medicine, particularly in the treatment of ischemic lesions and kidney functions. With a total of 2 patents, her work has the potential to improve the quality of life for many patients suffering from various conditions.
Latest Patents
One of her latest patents focuses on the "Use of treprostinil to treat and prevent ischemic lesions." This patent describes novel methods for using treprostinil or its derivatives to treat and prevent ischemic lesions, such as digital ulcers, in subjects with scleroderma, Buerger's disease, and Raynaud's phenomenon. The patent also includes kits for treatment that contain an effective amount of treprostinil or its derivatives.
Another significant patent is the "Use of treprostinil to improve kidney functions." This invention outlines methods for using treprostinil to enhance kidney functions, including urine output, and to treat symptoms associated with kidney malfunction or failure. Similar to her other patent, this invention also includes kits designed for improving kidney functions.
Career Highlights
Kathryn Bronstein is associated with United Therapeutics Corporation, where she continues to innovate and develop new medical treatments. Her work has garnered attention for its potential impact on patient care and treatment options.
Collaborations
Throughout her career, Kathryn has collaborated with notable colleagues, including Michael Wade and Roger Jeffs. These partnerships have contributed to her success and the advancement of her inventions.
Conclusion
Kathryn Bronstein is a remarkable inventor whose work in medical treatments showcases her dedication to improving patient outcomes. Her innovative patents reflect her commitment to addressing critical health issues, making her a valuable contributor to the field of medicine.